(R) -Larotrectinib
(R) -Larotrectinib is a potent TRK inhibitor with an IC50 value of 28.5 nM for TrkA. (R) -Larotrectinib can be used for researching cancer, inflammatory and certain infectious diseases[1]
Product Specifications
CAS Number
[1223404-68-9]
Product Name Alternative
(R) -LOXO-101; (R) -ARRY-470
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/r-larotrectinib.html
Solubility
10 mM in DMSO
Smiles
O=C(N1C[C@H](O)CC1)NC2=C3N=C(N4[C@@H](C5=CC(F)=CC=C5F)CCC4)C=CN3N=C2
Molecular Formula
C21H22F2N6O2
Molecular Weight
428.44
References & Citations
[1]Julia Haas, et al. SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS. WO2010048314A1 (compound 93)
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TrkA
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
